At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 74 enrolled
Drug / intervention
insulin glargine+ glulisine +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Basal Insulin in the Management of Patients With Diabetic Ketoacidosis
In Brief
A Phase 4 clinical trial evaluating insulin glargine+ glulisine and NPH + Regular insulin for Diabetic Ketoacidosis. Completed, enrolled 74 participants across 2 sites.
Detailed Summary
The study is a multicenter, randomized controlled trial to compare the safety and efficacy of insulin analogs and human insulins both during acute intravenous treatment and during the transition to subcutaneous insulin in patients with diabetic ketoacidosis (DKA).
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDiabetic Ketoacidosis
CountriesUnited States
CollaboratorsSanofi
Timeline
Phase 4CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartDec 2007
First PostedJan 2008
Primary CompletionJun 2008
Study CompletionAug 2008
TodayJul 2026
First PostedJan 10, 2008
Enrollment StartDec 1, 2007
Primary CompletionJun 1, 2008
Study CompletionAug 1, 2008
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 18.5 years ago
Interventions
insulin glargine+ glulisinedrug
Daily insulin glargine + glulisine before meals
NPH + Regular insulindrug
Split-mixed NPH + Regular insulin twice daily